Company Profile - Paratek Pharmaceuticals Inc

Introduction

Paratek Pharmaceuticals Inc (Paratek) is a e biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. The company focuses on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. Nuzyra (Omadacycline), the company’s lead product candidate is an USFDA-approved broad-spectrum antibiotic for the treatment of adults with community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections caused by susceptible bacteria. Its other product Seysara (sarecycline) is also an USFDA-approved drug for the treatment of inflammatory acne vulgaris in patients aged nine or older. Omadacycline is also being evaluated for the treatment of female patients with uncomplicated urinary tract infections and acute pyelonephritis. Paratek is headquartered in Boston, Massachusetts, the US